跳至主要内容
临床试验/CTRI/2018/05/013739
CTRI/2018/05/013739招募中未知

A study for efficacy and safety of intralesional bleomycin in common warts including palmo-plantar and periungual warts

Dr RPGMC Tanda0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • patients with palmoplantar and periungual warts more than 12 years of age requiring less than 2mg of bleomycin injection

排除标准

  • 1.Pregnant and lactating women
  • 2.Children <12 years
  • 3.Patients with Reynaudâ??s phenomenon or peripheral vascular disease
  • 4.Patients with immune suppression from any disease or drug therapy
  • 5.Patients with extensive warts requiring more than 2mg bleomycin

研究者

发起方
Dr RPGMC Tanda

相似试验

Intralesional bleomycin in treatment of warts. | 临床试验